Q0515 is the authoritative medical code for Injection, sermorelin acetate, 1 microgram. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, sermorelin acetate, 1 microgram (HCPCS Level II Q0515), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, sermorelin acetate, 1 microgram is a HCPCS Level II code Q0515 for a Medicare-covered supply, service, or procedure. Short description: Sermorelin acetate injection.
Codes in This Family (20)
Official HCPCS Level II classifications in the same code family as Q0515, with their registry titles.
- Q0500 — Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0501 — Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0502 — Mobility cart for pneumatic ventricular assist device, replacement only
- Q0503 — Battery for pneumatic ventricular assist device, replacement only, each
- Q0504 — Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
- Q0506 — Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0507 — Miscellaneous supply or accessory for use with an external ventricular assist device
- Q0508 — Miscellaneous supply or accessory for use with an implanted ventricular assist device
- Q0509 — Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
- Q0510 — Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
- Q0511 — Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
- Q0512 — Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
- Q0513 — Pharmacy dispensing fee for inhalation drug(s); per 30 days
- Q0514 — Pharmacy dispensing fee for inhalation drug(s); per 90 days
- Q0516 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
- Q0517 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
- Q0518 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
- Q0519 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
- Q0520 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days
- Q0521 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:
HCPCS Code Q0510
Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
HCPCS Code Q0511
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
HCPCS Code Q0512
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
HCPCS Code Q0516
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
HCPCS Code Q0517
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
HCPCS Code Q0518
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
HCPCS Code Q0519
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
HCPCS Code Q0520
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days